Navigation Links
New Data Reveals That Total Knee Replacement Can be Deferred Using Biologic and Bionic Meniscus Replacement Procedures
Date:2/9/2012

SAN FRANCISCO, Feb. 9, 2012 /PRNewswire/ -- This week at American Academy of Orthopedic Surgeons in San Francisco, a group of renowned orthopedic surgeons from around the world gathered to discuss the latest findings for meniscus transplantations.  New data on knee joint cartilage and meniscus transplantation presented at the 27th annual Meniscus Transplantation Study Group revealed that the meniscus tissue can be successfully replaced by tissue replacements such as cadaveric allografts, using artificial materials such as polyurethane scaffolds, and using polycarbonate-urethane implants. These advances bode well for all those who have developed knee pain or arthritis and want to avoid a total knee replacement.

The meniscus cartilage is the key shock absorber in the knee joint, and when injured, it is often removed. Loss of this critical structure often leads to joint pain and arthritis. Of the 1.4 million knee surgeries occurring in the United States each year, 98% of them result in the removal of meniscus tissue.

Eight investigators from five different countries presented on the science of meniscus replacement. From the United States, Kevin R. Stone, MD of the Meniscus Transplant Center at The Stone Clinic in San Francisco presented the largest and longest study of meniscus transplantation. The study spanned 16 years of data with approximately 80% success at improving patient pain and function in both pristine and arthritic knees. Many patients were able to return to a wide range of sporting activities after undergoing meniscus transplantation.

Mathew T. Provencher, MD, MC, USN of the US Navy presented data on the biomechanical changes in the knee for soldiers with a new meniscus and an osteotomy realignment procedure. The soldiers' pain was diminished and some were able to return to active duty.

Peter Verdonk, MD of Belgium unveiled a novel artificial meniscus implant made from polycarbonate-urethane. The implant is meant for patients who have a missing meniscus and knee pain, but whose knees are otherwise healthy. The data is preliminary but represents a new bionic approach to cartilage replacement. Dr. Verdonk also described the successes and failures of an artificial scaffold designed to regrow tissue called Actifit. The complication rate is still too high at 20%, but improvements are planned.

The global nature of cartilage loss and arthritis is being addressed and today offers young and old patient solutions that can be performed without removing bone or opening the joint, and permits return to sports.

 


'/>"/>
SOURCE Meniscus Transplant Center
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Recent Study Reveals Benefits to Women From DHEA Hormone
2. BASIS Science to Demo Basis Band at 2012 International CES; Reveals Design of Web Dashboard
3. GeckoSystems Reveals Concept Design for the 21st Century Wheelchair
4. Lilly Oncology Reveals Findings From Study of JAK2 Inhibitor for Blood Cancers at ASH Meeting
5. Jones Lang LaSalle Reveals 16 U.S. Regions Vying as Established or Emerging Markets for Life Sciences Industry
6. CVS/pharmacy Survey Reveals Consumer Misconceptions Standing in the Way of Getting a Flu Shot
7. Leading Medical Device Industry Resource Qmed Reveals Significant Enhancements Based on User-Driven Feedback
8. BASIS Reveals Details of Heart Rate and Health Tracker; Plans to Showcase Basis Band at Health 2.0
9. Lung Cancer Study Reveals Similar Outcomes for African-American and Caucasian Patients Treated With Alimta®
10. New Survey Reveals Pharmacists Are Increasingly Struggling to Care for Patients Amid Predatory Audits, Unfair Reimbursement Practices
11. Bayer Study Reveals Gaps in Perception of Veterinary Care Between Vets and Pet Owners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... communities in the greater Dallas, Miami, and Raleigh regions, is organizing an extended ... overcome a rare and deadly chromosome abnormality. , After struggling since birth with ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... the certification process to promote standards of excellence for the field of eating ... for March 22 – 25, 2018 in Orlando, Florida at the Omni Resort ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob ... sciatica in a new episode of "Success Files," which is an award-winning educational ... and investigates each subject in-depth with passion and integrity. , Sciatica occurs when ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
Breaking Medicine News(10 mins):